The safety and efficacy of antitumour necrosis factor-alpha therapy for inflammatory bowel disease in patients post liver transplantation: a case series.

Abstract

BACKGROUND The role of antitumour necrosis factor-alpha (anti-TNF) therapy for inflammatory bowel disease (IBD) among liver transplant recipients is largely unknown given the rarity of this population and the paucity of literature on the subject. AIM To investigate the safety and efficacy of anti-TNF therapy for refractory IBD in the post liver transplant… (More)
DOI: 10.1111/j.1365-2036.2012.05141.x

Topics

  • Presentations referencing similar topics